Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study
Go back to Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study| Revere Bank Laurel MD Com (NASDAQ: REVB) | Delayed: 1.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $16.00 | |||
| Open | $1.01 | 52 Week Low | $10.65 | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $0.99 | EPS | $0.00 | |||
| Volume | 7,734 | |||||
